Works matching IS 10781552 AND DT 2020 AND VI 26 AND IP 6
Results: 39
Development of a quality measures tool for the utilization of tyrosine kinase inhibitors in non-small cell lung cancer: An integrated specialty pharmacy initiative.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1441, doi. 10.1177/1078155220937754
- By:
- Publication type:
- Article
Corrigendum to Trends in use of primary prophylactic colony stimulating factors and neutropenia-related hospitalization in commercially insured patients receiving myelosuppressive chemotherapy in the United States: 2005–2017.
- Published in:
- 2020
- Publication type:
- Correction Notice
Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1429, doi. 10.1177/1078155220935564
- By:
- Publication type:
- Article
The introduction of a third CDK4/6 inhibitor does not change the cost-effectiveness profile in first and subsequent-lines after progression or relapse during previous endocrine therapy in patients with hormone receptor positive (HR+)/human epidermal receptor-2 negative (HER-2) advanced or metastatic breast cancer
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1486, doi. 10.1177/1078155220934531
- By:
- Publication type:
- Article
Age demographics of subjects enrolled in interventional phase 3 multiple myeloma clinical trials.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1475, doi. 10.1177/1078155220934162
- By:
- Publication type:
- Article
Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata, Japan.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1553, doi. 10.1177/1078155220932342
- By:
- Publication type:
- Article
Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1461, doi. 10.1177/1078155220931926
- By:
- Publication type:
- Article
Routine antiemetic prophylaxis with dexamethasone during COVID-19: Should oncologists reconsider?
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1482, doi. 10.1177/1078155220931921
- By:
- Publication type:
- Article
A review of Osimertinib in NSCLC and pharmacist role in NSCLC patient care.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1452, doi. 10.1177/1078155220930285
- By:
- Publication type:
- Article
Bortezomib-induced motor neuropathy: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1549, doi. 10.1177/1078155220904153
- By:
- Publication type:
- Article
Case of pembrolizumab-induced myocarditis presenting as torsades de pointes with safe re-challenge.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1544, doi. 10.1177/1078155220904152
- By:
- Publication type:
- Article
Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1538, doi. 10.1177/1078155220904147
- By:
- Publication type:
- Article
Life-threatening hypertriglyceridemia-induced pancreatitis related to alectinib successfully treated by plasmapheresis: A review of the literature on metabolic toxicities associated with anaplastic lymphoma kinase inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1533, doi. 10.1177/1078155220904141
- By:
- Publication type:
- Article
A fatal case of Immune thrombocytopenia secondary to the immune checkpoint inhibitor ipilimumab in a patient with BRAF wild type metastatic melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1530, doi. 10.1177/1078155220904139
- By:
- Publication type:
- Article
Synchronous duodenum and descending colon metastasis from primary lung neuroendocrine small-cell carcinoma: A case report and review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1524, doi. 10.1177/1078155220904133
- By:
- Publication type:
- Article
Management of a patient with primary mucinous testicular adenocarcinoma as a rare case with adjuvant and metastatic sequential treatments.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1520, doi. 10.1177/1078155220903374
- By:
- Publication type:
- Article
Severe terminal ileitis induced by single-agent nivolumab administered every four weeks.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1516, doi. 10.1177/1078155220903367
- By:
- Publication type:
- Article
Hyperpigmentation due to imatinib: A rare case of cutaneous involvement.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1511, doi. 10.1177/1078155220903364
- By:
- Publication type:
- Article
Hepatoid adenocarcinoma of the lung and the review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1505, doi. 10.1177/1078155220903360
- By:
- Publication type:
- Article
Ibrutinib-induced polyneuropathy: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1501, doi. 10.1177/1078155220903357
- By:
- Publication type:
- Article
A multiple myeloma patient who developed ischemic colitis during lenalidomide treatment: A rare case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1499, doi. 10.1177/1078155219900910
- By:
- Publication type:
- Article
Management of a glottic squamous cell carcinoma with cutaneous metastasis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1495, doi. 10.1177/1078155219900782
- By:
- Publication type:
- Article
Acute cerebellar toxicity induced by high dose of cytarabine (HiDAC): A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1492, doi. 10.1177/1078155219898747
- By:
- Publication type:
- Article
Taxane-induced peripheral neuropathy and quality of life in breast cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1421, doi. 10.1177/1078155219898511
- By:
- Publication type:
- Article
The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1415, doi. 10.1177/1078155219898504
- By:
- Publication type:
- Article
Parecoxib as an adjunct therapy for the treatment of refractory non-surgical cancer pain.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1407, doi. 10.1177/1078155219897744
- By:
- Publication type:
- Article
Protective role of black seed oil in doxorubicin-induced cardiac toxicity in children with acute lymphoblastic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1397, doi. 10.1177/1078155219897294
- By:
- Publication type:
- Article
Evaluation of pharmacist interventions in a head and neck medical oncology clinic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1390, doi. 10.1177/1078155219897129
- By:
- Publication type:
- Article
Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: Is there room for improvement?
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1382, doi. 10.1177/1078155219896396
- By:
- Publication type:
- Article
Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1374, doi. 10.1177/1078155219896395
- By:
- Publication type:
- Article
Evaluation of fosaprepitant-associated hypersensitivity reactions at a National Cancer Center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1369, doi. 10.1177/1078155219895312
- By:
- Publication type:
- Article
Cancer health promotion in Ghana: A survey of community pharmacists' perception and barriers.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1361, doi. 10.1177/1078155219893742
- By:
- Publication type:
- Article
Integration of a nausea and vomiting assessment tool into antineoplastic management of pediatric oncology patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1353, doi. 10.1177/1078155219892666
- By:
- Publication type:
- Article
Evaluation of awareness and understanding of cancer immunotherapy among healthcare professionals in eastern Saudi Arabia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1343, doi. 10.1177/1078155219891651
- By:
- Publication type:
- Article
Effects of adding necitumumab to first-line chemotherapy in patients with stage IV non-small-cell lung cancer: Meta-analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1331, doi. 10.1177/1078155219891631
- By:
- Publication type:
- Article
Impact of transitioning inpatient chemotherapy regimens to the outpatient setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1324, doi. 10.1177/1078155219891566
- By:
- Publication type:
- Article
Measurement of the leak rate of masks used for anticancer drug handling using a mask fitting tester.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1318, doi. 10.1177/1078155219891210
- By:
- Publication type:
- Article
Parenteral cytotoxic drug wastage at a tertiary hospital in Kuala Lumpur: How much and why?
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1306, doi. 10.1177/1078155219891209
- By:
- Publication type:
- Article
Obesity is not strongly associated with increased risk for febrile neutropenia during levofloxacin prophylaxis in patients with hematological malignancies receiving intermediate-risk myelosuppressive chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1301, doi. 10.1177/1078155219890403
- By:
- Publication type:
- Article